Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Estrogen Administration for the Treatment of NASH in Postmenopausal Women

NCT04833140 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04833140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04833140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Estrogen Administration for the Treatment of NASH in Postmenopausal Women
Lead sponsor
Massachusetts General Hospital
Phase
Phase 3
Overall status
Active, not recruiting
Start date
December 2, 2021
Completion date
July 9, 2027
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nash - nonalcoholic steatohepatitis